Board Member at Five Prime Therapeutics, Inc.
Franklin M. Berger, 68, has served as a member of our Board since October 2014. Since 2008, Mr. Berger has served as an independent consultant to biopharmaceutical companies rendering strategic and financial advice as the Managing Director of FMB Research. Mr. Berger worked at Sectoral Asset Management as a founder of the small-cap focused NEMO Fund from January 2007 through June 2008. From May 1998 to March 2003, he served at J.P. Morgan Securities Inc., most recently as Managing Director, Equity Research and Senior Biotechnology Analyst. Previously, Mr. Berger served in similar capacities at Salomon Smith Barney and Josephthal & Co. Mr. Ber ...
Source: Tocagen Inc. on 03/30/2018
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Franklin M. Berger. More specifically, you'll be able to:
Access over 200,000 executive and board member profiles.
Example: Franklin M. Berger
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.